🚨Calling all #ASGCT2025 attendees joining us in New Orleans: Remember to book your housing in our room block by 11:59 p.m. (CT) TONIGHT! Don't miss your chance to secure the lowest hotel room rates and convenient accommodations. Log into your ASGCT account to manage your hotel room booking! https://lnkd.in/g3CRFFAY
American Society of Gene & Cell Therapy
Non-profit Organizations
Waukesha, WI 32,013 followers
ASGCT is the primary membership organization for professionals working in gene and cell therapy.
About us
The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
- Website
-
http://www.asgct.org
External link for American Society of Gene & Cell Therapy
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- Waukesha, WI
- Type
- Nonprofit
- Founded
- 1996
Locations
-
Primary
Get directions
20800 Swenson Dr.
Suite 300
Waukesha, WI 53186, US
Employees at American Society of Gene & Cell Therapy
-
Ravishankar Vadali
-
Serene Forte, PhD, MPH
Rare Diseases | Genetic Medicines | Medical Affairs | Strategy and Leadership | Business Development | Commercialization
-
Aravind Asokan
Professor@Duke University | Biotech Founder
-
Ahmed S. MOUSA, MD
Executive | Strategy | Business Development | Democratize Innovation | Biotech Ecosystem Catalyst | Cell & Gene Therapy | Venture Creation |
Updates
-
🎙️ Register for free: Explore cutting-edge advancements in the use of AAV vectors for #genetherapy research in Japan. This event on April 8 at 7 p.m. CT brings together leading scientists, researchers, and professionals in the field to discuss innovative approaches, challenges, and breakthroughs in gene delivery systems, specifically focusing on AAV technology. https://lnkd.in/eVTwjJWs
-
-
🎉 25 Years of 𝘔𝘰𝘭𝘦𝘤𝘶𝘭𝘢𝘳 𝘛𝘩𝘦𝘳𝘢𝘱𝘺: A Special Anniversary Webinar Join us for a 𝗙𝗥𝗘𝗘 landmark scientific webinar celebrating 25 years of cell and gene therapy research. Since its launch on January 1, 2000, 𝘔𝘰𝘭𝘦𝘤𝘶𝘭𝘢𝘳 𝘛𝘩𝘦𝘳𝘢𝘱𝘺 has established itself as the premier journal in genetic medicine, achieving an impact factor exceeding 10 by 2020. 𝗘𝗱𝗶𝘁𝗼𝗿-𝗶𝗻-𝗖𝗵𝗶𝗲𝗳 𝗗𝗿. 𝗝𝗼𝘀𝗲𝗽𝗵 𝗖. 𝗚𝗹𝗼𝗿𝗶𝗼𝘀𝗼 𝗜𝗜𝗜 𝗵𝗮𝘀 𝗰𝘂𝗿𝗮𝘁𝗲𝗱 𝘁𝗵𝗶𝘀 𝘀𝗽𝗲𝗰𝗶𝗮𝗹 𝘀𝗲𝘀𝘀𝗶𝗼𝗻 𝗳𝗲𝗮𝘁𝘂𝗿𝗶𝗻𝗴 𝗱𝗶𝘀𝘁𝗶𝗻𝗴𝘂𝗶𝘀𝗵𝗲𝗱 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗼𝗿𝘀 𝘁𝗼 𝘁𝗵𝗲 𝗷𝗼𝘂𝗿𝗻𝗮𝗹'𝘀 𝟮𝟱𝘁𝗵 𝗮𝗻𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗿𝘆 𝗶𝘀𝘀𝘂𝗲 𝘄𝗵𝗼 𝘄𝗶𝗹𝗹 𝗲𝘅𝗽𝗹𝗼𝗿𝗲 𝘁𝗵𝗲 𝗮𝗱𝘃𝗮𝗻𝗰𝗲𝘀 𝘁𝗵𝗮𝘁 𝗵𝗮𝘃𝗲 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗲𝗱 𝘁𝗵𝗲 𝗖𝗚𝗧 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲: 𝗪𝗵𝗲𝗻: Wednesday, April 23, 2025 | 11:00 AM - 12:00 PM CT 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: • 𝗗𝗿. 𝗧𝗲𝗿𝗲𝗻𝗰𝗲 𝗥. 𝗙𝗹𝗼𝘁𝘁𝗲 (UMass Chan Medical School): "Gene Therapy Then and Now: A Look Back at Changes in the Field Over the Past 25 Years" • 𝗗𝗿. 𝗥. 𝗝𝘂𝗱𝗲 𝗦𝗮𝗺𝘂𝗹𝘀𝗸𝗶 (UNC Gene Therapy Center): "AAV Vector Development, Back to the Future" • 𝗗𝗿. 𝗡𝗼𝘂𝗿 𝗦𝗵𝗼𝗯𝗮𝗸𝗶 (Perelman School of Medicine, UPenn): "From Concept to Cure: The Evolution of CAR-T Cell Therapy" Don't miss this opportunity to gain insights from pioneers who have transformed cell and gene therapy. Register here! https://lnkd.in/eiy85pPU
This content isn’t available here
Access this content and more in the LinkedIn app
-
🔔 REMINDER: All Empowering Patients 2025 registrants will have exclusive 30-day on-demand access to all sessions through our event platform. Afterward, ASGCT will make this valuable content available on YouTube, enabling organizations to easily share these patient-centered resources with their communities. This collaborative approach ensures that knowledge reaches those who need it most - don't miss this opportunity to extend the impact of this event! Thank you to AllMyHealth for this written summary! #EmpoweringPatients2025 #ASGCT #PatientAdvocacy
🚀 Patients are the future of cell and gene therapy 🚀 Last week, we had the privilege of attending American Society of Gene & Cell Therapy’s Empowering Patients 2025 Summit, where patient advocates, scientists, and regulators came together to shape the future of gene therapy. Our top takeaways: ✅ Patients and caregivers are essential partners in research, not just participants. ✅ Understanding clinical trials is critical - knowledge is power in navigating options. ✅ Regulatory agencies are listening - patient voices help shape approvals. ✅ Manufacturing challenges remain, but overcoming them is key to access. A powerful message throughout the summit: The future of gene therapy isn’t just about scientific progress - it’s about patient-driven progress. If you missed the event, check out our recap below 👇 AllMyHealth brings together the latest research, clinical trial updates, and community events from across the rare disease space each week - so you don’t have to. Stay informed, stay empowered. Want to stay updated on the latest news about your disease area? Sign up for our newsletter(s): https://lnkd.in/eRcGApVr Want to sponsor one of our newsletters or guides? Reach out! https://lnkd.in/eB4CbcgQ #GeneTherapy #CellTherapy #PatientAdvocacy #RareDisease #ClinicalTrials #EmpowerPatients Alexis Starosta Allison Bradbury Sharon King Kimberly Goodspeed, MD Kristin Van Goor Paula Cannon Steven Gray Raymond Wang Amy Waldman Heather Lau MD MS Terry Flotte Cara O'Neill The FDA's Peter Marks Amy Raymond, PhD, PMP Brendan Hayes, MPH, CPH Amanda Moore Kelly Brazzo Sarah Cortell Vandersypen, CFRE Jennifer Siedman Megan Maack Stephanie Lewis Eli Lilly and Company Ultragenyx Bayer Kite Pharma
-
🔊 One more week to elect the next members of the ASGCT Board of Directors! 🔊 ✔️ If you're an ASGCT Member or Transitional Member, please take a few minutes to cast your vote in ASGCT Elections through next Friday, April 11. ✔️ Learn more about the candidates and cast your ballot now! https://lnkd.in/gyb5Qk23 #genetherapy
-
-
📰 Check out the latest issue of ASGCT Insider, the newsletter from ASGCT's Communications Committee! In this issue, read about the FDA approval of #Encelto, the first and only treatment for MacTel type 2, as well as a collection of journal articles and clinical development news. Thank you to this month's contributors: Jon Brudvig, PhD; Christopher Leidli, MS, MBA; Tsai-Yu Lin, PhD; Florie Borel, PhD; and Benjamin McLeod
-
🔜 #ASGCT2025 in #NOLA is just a few weeks away and we can't wait! Thanks for the shout out, New Orleans & Company! What else will you discover in New Orleans this May? View the full video + make sure you register to join us. #celltherapy #genetherapy #annualmeeting https://lnkd.in/gKwcfrWm
-
🩸 March is #HemophiliaAwarenessMonth! Hemophilia is a genetic disease that prevents blood from clotting properly, leading to prolonged internal and external bleeding. Recent #CGT approvals and ongoing research are opening new possibilities for better treatment options and improved quality of life. Learn more about how #genetherapy is changing the trajectory of hemophilia care: https://lnkd.in/gj5UWGW2
-
What we're reading: MIT engineers turn skin cells directly into neurons for cell therapy, written by Anne Trafton | MIT News "A new, highly efficient process for performing this conversion could make it easier to develop therapies for spinal cord injuries or diseases like ALS." Read more here: https://lnkd.in/eJq4h6cj
-
-
📢 Have you voted yet? ASGCT Election voting is open through April 11 for all current Members and Transitional Members! https://lnkd.in/gyb5Qk23
🔊 Calling all Members + Transitional Members: It's election season through April 11 at ASGCT! We need your help to select five new members of the ASGCT Board of Directors! Here are this year's candidates: ✔️ Vice President: Barry Byrne + Isabelle Rivière ✔️ Secretary: Aravind Asokan + Marcela Maus ✔️ At-Large Director: Agnieszka Czechowicz, MD, PhD + Laura Sepp-Lorenzino, Ph.D. ✔️ At-Large Director: Steven Gray + Fyodor Urnov ✔️ At-Large Director, Membership Council Chair: Allison Bradbury + Tippi MacKenzie Log in and VOTE here: https://lnkd.in/gyb5Qk23
-